Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axogen (AXGN) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Axogen (AXGN) over the last 10 years, with Q3 2025 value amounting to -$28000.0.

  • Axogen's Asset Writedowns and Impairment fell 13684.21% to -$28000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $404000.0, marking a year-over-year decrease of 3726.71%. This contributed to the annual value of $650000.0 for FY2024, which is 33985.24% up from last year.
  • Axogen's Asset Writedowns and Impairment amounted to -$28000.0 in Q3 2025, which was down 13684.21% from $199000.0 recorded in Q2 2025.
  • In the past 5 years, Axogen's Asset Writedowns and Impairment ranged from a high of $1.7 million in Q2 2021 and a low of -$769000.0 during Q4 2022
  • Moreover, its 5-year median value for Asset Writedowns and Impairment was $395000.0 (2021), whereas its average is $358631.6.
  • Per our database at Business Quant, Axogen's Asset Writedowns and Impairment soared by 24626.87% in 2021 and then crashed by 26573.28% in 2022.
  • Over the past 5 years, Axogen's Asset Writedowns and Impairment (Quarter) stood at $464000.0 in 2021, then plummeted by 265.73% to -$769000.0 in 2022, then skyrocketed by 105.2% to $40000.0 in 2023, then rose by 15.0% to $46000.0 in 2024, then crashed by 160.87% to -$28000.0 in 2025.
  • Its last three reported values are -$28000.0 in Q3 2025, $199000.0 for Q2 2025, and $187000.0 during Q1 2025.